Bio-Rad Laboratories Class A
302 hedge funds and large institutions have $4.58B invested in Bio-Rad Laboratories Class A in 2017 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 101 increasing their positions, 102 reducing their positions, and 24 closing their positions.
138% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 24
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more funds holding
Funds holding: 271 → 302 (+31)
7% more capital invested
Capital invested by funds: $4.27B → $4.58B (+$318M)
0.34% less ownership
Funds ownership: 78.25% → 77.91% (-0.34%)
1% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 102
74% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $8.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$52M |
| 2 |
D.E. Shaw & Co
New York
|
+$30.2M |
| 3 |
SC
Samlyn Capital
New York
|
+$25.3M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$23.7M |
| 5 |
Millennium Management
New York
|
+$23.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$62.2M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$46.9M |
| 3 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$41.4M |
| 4 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$24.4M |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$21.4M |
BIO Hedge Fund Activity: Q4 2017 in Review
302 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2017, worth a combined $4.58B — up 7.5% from $4.27B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new BIO positions and 24 closed out — a net gain of 33 holders — while 101 added to existing stakes and 102 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $52M. The largest seller was Ariel Investments, cutting an estimated $62.2M.
- 302 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2017, up from 271 in Q3 2017.
- Funds reported $4.58B of Bio-Rad Laboratories Class A stock for Q4 2017, up 7.5% quarter-over-quarter.
- 57 funds opened new Bio-Rad Laboratories Class A positions in Q4 2017 and 24 closed out, a net change of +33 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2017 was Renaissance Technologies, an estimated $52M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2017 was Ariel Investments, an estimated $62.2M sold.
Based on aggregated 13F filings for Q4 2017.